Cardiovascular Clinical Studies

This channel includes news and new technology innovations from cardiovascular clinical trials. These clinical studies include all cardiac subspecialties.

News | Cardiac Imaging

April 3, 2020 — Patients who experience chest pain and have abnormal results on a cardiac stress test but who do not ...

Home April 03, 2020
Home
Videos | Structural Heart

Basel Ramlawi, M.D., chairman of The Heart and Vascular Center at Valley Health System in Virginia, director of the ...

Home April 03, 2020
Home
News | Sudden Cardiac Arrest

April 2, 2020 — Among patients who had an out-of-hospital cardiac arrest, intravenous sodium nitrite given by paramedics ...

Home April 02, 2020
Home
News | Renal Denervation

April 1, 2020 — Three months after undergoing renal denervation (RDN), patients with untreated high blood pressure had ...

Home April 01, 2020
Home
News | Renal Denervation

April 1, 2020 — Three months after undergoing renal denervation (RDN), patients with untreated high blood pressure had ...

Home April 01, 2020
Home
Videos | Structural Heart

A review of the PARTNER 3 Low-Risk Trial with Michael Mack, M.D., chairman, cardiovascular service line,  Baylor Scott ...

Home April 01, 2020
Home
News | Coronavirus (COVID-19)

March 31, 2020 — Four metropolitan Detroit hospital systems and a leading research university announced a collaboration ...

Home March 31, 2020
Home
News

March 30, 2020 — Smokers who received smoking cessation counseling and used electronic cigarettes (e-cigarettes) ...

Home March 30, 2020
Home
News | Cardiovascular Surgery

March 30, 2020 — Patients undergoing coronary bypass graft (CAGB) surgery lived longer and had better outcomes when ...

Home March 30, 2020
Home
News | Heart Valve Technology

March 30, 2020 — Edwards Lifesciences Corp. announced it is temporarily pausing new enrollments in its active pivotal ...

Home March 30, 2020
Home
News | Heart Valve Technology

March 30, 2020 — Patients in the United Kingdom (U.K.) who underwent transcatheter aortic valve replacement (TAVR) did ...

Home March 30, 2020
Home
PARTNER 3 trial shows positive results for Sapien 3 in low-risk surgical patients. #ACC20 #ACC2020 #Sapien3 #TAVR
Feature | Heart Valve Technology

March 30, 2020 — Low-risk patients undergoing transcatheter aortic valve repair (TAVR) at two years did just as well ...

Home March 30, 2020
Home
News | Heart Valve Technology

March 29, 2020 — Worse than expected outcomes were found for survival and quality of life among patients undergoing ...

Home March 29, 2020
Home
News | Heart Failure

March 29, 2020 — Patients with worsening heart failure and reduced ejection fraction who received the investigational ...

Home March 29, 2020
Home
Patients with bicuspid, or two-leaflet, aortic valves who undergo transcatheter aortic valve replacement (TAVR) procedures had a high rate of success and low risk of death or disabling stroke at 30 days, according to new data presented at the American College of Cardiology (ACC) 2020 Scientific Session. #ACC20 #ACC2020
Feature | Heart Valve Technology | Dave Fornell, Editor

March 29, 2020 — Patients with bicuspid, or two-leaflet, aortic valves who undergo transcatheter aortic valve ...

Home March 29, 2020
Home
Subscribe Now